Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C22H34N2O2 |
Molecular Weight | 358.5176 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)C[C@H]1[C@H](OC(=O)N1CCCN2CCCCCC2)C3=CC=CC=C3
InChI
InChIKey=DQNMZSIJHFEYTM-LEWJYISDSA-N
InChI=1S/C22H34N2O2/c1-18(2)17-20-21(19-11-6-5-7-12-19)26-22(25)24(20)16-10-15-23-13-8-3-4-9-14-23/h5-7,11-12,18,20-21H,3-4,8-10,13-17H2,1-2H3/t20-,21+/m0/s1
DescriptionSources: http://www.chemdrug.com/article/8/3285/16420167.html
Sources: http://www.chemdrug.com/article/8/3285/16420167.html
Ipenoxazone (NC 1200) is a muscle relaxant that is under investigation (phase II) for the treatment of Alzheimer's Dementia, Cognition Disorders. It acts as an Ionotropic glutamate receptor antagonist.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2094124 Sources: http://www.ncbi.nlm.nih.gov/pubmed/15277038 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
Sample Use Guides
In Vitro Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/3345898
NC-1200 (IPENOXAZONE) acted as a Ca-blocker in the guinea pig taenia caecum. The pA2-value was 5.67
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C1509
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
104454-71-9
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
C76780
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
100000083139
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
7214
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
DTXSID601318288
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
839F26EVAQ
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
65882
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
CHEMBL2104917
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY | |||
|
SUB08271MIG
Created by
admin on Fri Dec 15 16:35:25 GMT 2023 , Edited by admin on Fri Dec 15 16:35:25 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)